Elanco (ELAN) EVP Rajeev Modi reports purchase of 4,500 shares

Rhea-AI Filing Summary

Elanco Animal Health executive Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation, reported an insider purchase of company stock. On December 11, 2025, he acquired 4,500 shares of Elanco common stock at a price of $21.33 per share.

After this transaction, Modi directly beneficially owns 123,082 Elanco shares. This total includes 1,579 shares acquired on January 31, 2025 and 205 shares acquired on April 30, 2025 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Modi Rajeev A.

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS IN 46221

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SEE REMARKS

3. Date of Earliest Transaction (Month/Day/Year)
12/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/11/2025		P		4,500	A	$21.33	123,082(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 1,579 shares acquired on January 31, 2025 and 205 shares acquired on April 30, 2025 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan

Remarks:

Executive Vice President U.S. Pet Health and Global Digital Transformation

	/s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Elanco (ELAN) executive Rajeev A. Modi report?

Rajeev A. Modi reported acquiring 4,500 shares of Elanco Animal Health Inc. common stock in a transaction dated December 11, 2025.

At what price did Rajeev A. Modi buy Elanco (ELAN) shares?

He acquired the 4,500 Elanco common shares at a price of $21.33 per share.

How many Elanco (ELAN) shares does Rajeev A. Modi own after the reported trade?

Following the reported transaction, Rajeev A. Modi beneficially owns 123,082 shares of Elanco common stock directly.

What is Rajeev A. Modi’s role at Elanco Animal Health Inc. (ELAN)?

Rajeev A. Modi is identified as an officer, serving as Executive Vice President U.S. Pet Health and Global Digital Transformation.

Were any of Rajeev A. Modi’s Elanco (ELAN) shares acquired through an employee stock plan?

Yes. His holdings include 1,579 shares acquired on January 31, 2025 and 205 shares acquired on April 30, 2025 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan.

Is Rajeev A. Modi’s ownership in Elanco (ELAN) reported as direct or indirect?

The 123,082 Elanco shares beneficially owned following the transaction are reported as direct ownership.